These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Morphological findings after intracoronary application of endothelin-1 in dog.
    Author: Sidlo J, Bernadic M, Zlatos L, Holzerová J, Maasová D, Hulín I.
    Journal: Bratisl Lek Listy; 1996 Oct; 97(10):611-3. PubMed ID: 9001133.
    Abstract:
    BACKGROUND: Endothelin-1 is a strong vasoconstrictor, high doses of which can cause prolonged vasoconstriction. MAIN PURPOSE: The aim of our study was to investigate as to whether the endothelin-induced vasoconstriction causes irreversible morphological changes in the myocardium in experimental animals and to verify the applicability of this experimental model in the study of the impact of endothelin. METHODS: Fourteen anaesthetized dogs were administered with 400 pmol of endothelin. The substance was applied into the left anterior descending coronary artery. The serum activities of AST, CK and LD enzymes, and changes in electric activity of the myocardium were monitored. The heart of one of the dogs was analyzed morphologically. RESULTS: Following the application of endothelin, vasoconstriction supervened, lasting from 25 to 27 minutes. Five dogs developed fibrillation of ventricles and died. The dogs which survived yielded changes in the activities of the investigated enzymes and changes in electric activity which were typical of focal impairment of the myocardium in sense of necrosis. Morphologically the changes represented disseminated fibrosis or minor scars in the myocardium. CONCLUSIONS: Application of endothelin into the coronary artery can cause irreversible structural changes in the myocardium. (Fig. 1, Ref. 18.).
    [Abstract] [Full Text] [Related] [New Search]